Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.870 | 0.900 | 10 | 2006 | 2020 | ||||||
Fasting blood glucose measurement
|
212 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.800 | 1.000 | 4 | 2010 | 2019 | ||||||
Body mass index
|
2689 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||||
Coronary heart disease
|
1178 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.800 | 1.000 | 2 | 2011 | 2016 | ||||||
Gestational Diabetes
|
224 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||||
Atrial Fibrillation
|
584 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Cerebrovascular accident
|
591 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Diabetes
|
710 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Diabetes Mellitus
|
824 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Diastolic blood pressure
|
1037 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
elevated blood glucose level
|
111 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Fasting blood sugar result
|
113 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Glucose measurement
|
111 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Heart failure
|
201 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Hematocrit procedure
|
216 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
High density lipoprotein measurement
|
1440 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Neoplasms
|
1641 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Polycystic Ovary Syndrome
|
363 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Serum total cholesterol measurement
|
1243 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Systolic Pressure
|
1931 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Triglycerides measurement
|
1418 | 0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 |